🇺🇸 FDA
Patent

US 9200282

Compositions and methods for inhibiting expression of an RNA from west nile virus

granted A61PA61P31/14

Quick answer

US patent 9200282 (Compositions and methods for inhibiting expression of an RNA from west nile virus) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P31/14